Tech Company Financing Transactions
SNIPR Biome Funding Round
On 8/7/2025, SNIPR Biome raised $41 million in Series B funding from Cystic Fibrosis Foundation, Lundbeckfonden BioCapital and Wellington Partners.
Transaction Overview
Company Name
Announced On
8/7/2025
Transaction Type
Venture Equity
Amount
$41,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to support the development of a CRISPR-Cas therapy specifically targeting airway infections caused by Pseudomonas aeruginosa in people with cystic fibrosis (CF).
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Lersø Parkallé 44
Copenhagen, 2100
Denmark
Copenhagen, 2100
Denmark
Phone
Undisclosed
Website
Email Address
Overview
SNIPR Biome is the leading CRISPR Microbiome company. As a growing company we are always looking for new talents to join our team in the capital of Denmark, Copenhagen. Our main goal is to engineer microbiomes using CRISPR technology, to treat a number of serious and life-threatening diseases, ranging from IBD, Multi-drug resistant infections to cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Morten Sommer
Chief Executive Officer
Christian Grøndahl
Chief Medical Officer
Jonas Hink
Co-Founder
Jasper Clube
Browse more venture capital transactions:
Prev: 8/7/2025: Metaforms venture capital transaction
Next: 8/7/2025: Maxwell Biosciences venture capital transaction
Share this article
About Our VC Transactions Data
We document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs